Loading...
| A03556 | Pages: NA | Dec 2021 | 4710 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Self-monitoring Blood Glucose Strips Market
Request Now !Blood glucose monitoring devices are medical devices that are used to monitor blood glucose in diabetic patients or other glucose related diseases. Self-monitoring blood glucose strips are a type of blood glucose monitoring device that monitor blood glucose levels and aids in understanding ones diabetes control; it also informs changes to improve ones control. The major factor that drives the growth of this market is the increase in diabetic population globally.
In addition, the introduction of novel products such as test strips made from Indian silk and positive reimbursement of self-monitoring blood glucose devices in developed economies will also aid in the growth of this market. However, low awareness among healthcare professionals in developing economies will impede the market growth. In addition, self-monitoring blood glucose strips are mostly utilized in homes by general population, which is why chances of error increases that further restricts the growth of this market. Moreover, several technological advancements in untapped economies will result in more user friendly test strips with fewer complications, thereby creating more lucrative opportunities for this market.
The self-monitoring blood glucose strips market is segmented based on product type, end user, and geography. Based on product type this market is segmented into drop blood type blood glucose strips and siphon type blood glucose strips. Based on end user this market is segmented into hospitals, clinics, and homecare. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as LifeScan, Inc., Medtronic PLC, Roche Diagnostics, Abbott Laboratories, BD Medical, Beurer GmbH, MediWise Ltd., Menarini Diagnostics, Bioptik Technology, Pulsatom Healthcare and AgaMatrix, Inc. have also been provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 SELF-MONITORING BLOOD GLUCOSE STRIPS MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. DROP BLOOD TYPE BLOOD GLUCOSE STRIPS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. SIPHON TYPE BLOOD GLUCOSE STRIPS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 SELF-MONITORING BLOOD GLUCOSE STRIPS MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Key market trends
5.3. CLINICS
5.3.1. Key market trends
5.4. HOMECARE
5.4.1. Key market trends
CHAPTER 6 SELF-MONITORING BLOOD GLUCOSE STRIPS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Self-Monitoring Blood Glucose Strips Market by Product Type
6.2.5. North America Self-Monitoring Blood Glucose Strips Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Self-Monitoring Blood Glucose Strips Market by Product Type
6.3.5. Europe Self-Monitoring Blood Glucose Strips Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Self-Monitoring Blood Glucose Strips Market by Product Type
6.4.5. Asia-Pacific Self-Monitoring Blood Glucose Strips Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Self-Monitoring Blood Glucose Strips Market by Product Type
6.5.5. LAMEA Self-Monitoring Blood Glucose Strips Market by End User
CHAPTER 7 COMPANY PROFILES
7.1. LIFESCAN, INC.
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. MEDTRONIC PLC
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. ROCHE DIAGNOSTICS
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. ABBOTT LABORATORIES
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. BD MEDICAL, BEURER GMBH
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. MEDIWISE LTD.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. MENARINI DIAGNOSTICS
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. BIOPTIK TECHNOLOGY
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. PULSATOM HEALTHCARE
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. AGAMATRIX, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
